Beijing Health Guard Biotechnology (BJSE:920575) Construction In Progress: ¥788.23 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920575 Beijing Health Guard Biotechnology Inc BJSE:920575
47 GF Score
Price ¥5.59
GF Value ¥7.92
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Beijing Health Guard Biotechnology Construction In Progress?

Beijing Health Guard Biotechnology BJSE:920575 47 Construction In Progress is ¥788.23 Mil as of Jun. 2026. GuruFocus rates BJSE:920575 with a GF Score™ of 47/100 and a GF Value™ of ¥7.92 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Beijing Health Guard Biotechnology's quarterly construction in progress increased from Dec. 2025 (¥766.98 Mil) to Mar. 2026 (¥780.69 Mil) and increased from Mar. 2026 (¥780.69 Mil) to Jun. 2026 (¥788.23 Mil).

Beijing Health Guard Biotechnology's annual construction in progress increased from Dec. 2023 (¥723.23 Mil) to Dec. 2024 (¥815.32 Mil) but then declined from Dec. 2024 (¥815.32 Mil) to Dec. 2025 (¥766.98 Mil).

Beijing Health Guard Biotechnology Construction In Progress Historical Data

* Premium members only.

The historical data trend for Beijing Health Guard Biotechnology's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Health Guard Biotechnology Construction In Progress Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.61 401.74 723.23 815.32 766.98

Beijing Health Guard Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 829.77 838.88 766.98 780.69 788.23
BJSE:920575
47GF Score
Beijing Health Guard Biotechnology Inc BJSE:920575
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Health Guard Biotechnology Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥788.23 Mil mean?
Beijing Health Guard Biotechnology (BJSE:920575) has a Construction In Progress of ¥788.23 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Health Guard Biotechnology and its competitors.
Is Beijing Health Guard Biotechnology's Construction In Progress too high?
Beijing Health Guard Biotechnology's current Construction In Progress is ¥788.23 Mil. Overall, Beijing Health Guard Biotechnology has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Health Guard Biotechnology's Construction In Progress compare to VRTX and REGN?
Beijing Health Guard Biotechnology's Construction In Progress of ¥788.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Health Guard Biotechnology and its competitors. Beijing Health Guard Biotechnology's current Construction In Progress is ¥788.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health Guard Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology (BJSE:920575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.92, compared to a current price of ¥5.59 — trading 29.4% below its estimated fair value. The current Construction In Progress is ¥788.23 Mil. Beijing Health Guard Biotechnology's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Beijing Health Guard Biotechnology (BJSE:920575), the current Construction In Progress is ¥788.23 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued. The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92. GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.

Key valuation signals for BJSE:920575:

  • Construction In Progress: ¥788.23 Mil
  • GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
  • GF Score™: 47/100 with 10 warning signs

No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Health Guard Biotechnology Business Description

Address No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score

Get the complete analysis for BJSE:920575

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.59
Price
¥7.92
GF Value